Trial Profile
The Safety of Celecoxib (Celebrex) in Patients With Crohn's Disease
Status:
Discontinued
Phase of Trial:
Phase IV
Latest Information Update: 16 Jul 2016
Price :
$35
*
At a glance
- Drugs Celecoxib (Primary)
- Indications Crohn's disease
- Focus Therapeutic Use
- 23 Sep 2010 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov.
- 22 Sep 2009 New trial record.